MAPT and Alzheimer disease: In recent studies, the cerebrospinal fluid p-tau/Aβ42 and Aβ42/Aβ40 ratios have been described to have high sensitivity, specificity, and overall diagnostic performance for intermediate-high AD neuropathologic changes (Mattsson-Carlgren et al., 2022).